-
State-Specific Prevalence of Obesity Among Adults -- United States, 2007
Reducing the proportion of adults who are obese to 15% is a Healthy People 2010 objective that was not met by any state in 2005. What is the prevalence of obesity among adults in the US in 2007?
Journal Article, August 28, 2008
-
After ENHANCE, Now SEAS: What Do We Know, and How Do We Know It?
With more data about Vytorin and ezetimibe being presented at the European cardiology meeting, in this video blog Dr. Black discusses what we should think about the results, given their context.
Expert Viewpoint, August 28, 2008
-
Looking Out for Others
What do you do when serving others becomes drudgery?
Journal Article Commentary, August 27, 2008
-
CME
Islet Cell Dysfunction: An Underlying Defect in the Pathophysiology of Type 2 Diabetes
l
Slide/Lecture Presentation, August 27, 2008
-
CME
Translating Incretin Biology Into Therapeutic Options for the Management of Type 2 Diabetes
Slide/Lecture Presentation, August 27, 2008
-
CME
Panel Discussion
Slide/Lecture Presentation, August 27, 2008
-
CME
The Unraveling of Incretin Biology: New Dimensions in the Management of Type 2 Diabetes
Review the mechanisms by which incretin hormones affect glucose homeostasis and the role of incretin-based therapies, alone or in combination with other drug classes, in the management of type 2 diabetes.
Slide/Lecture Presentation, August 27, 2008
-
Frequency and Characteristics of TBII-seronegative Patients in a Population With Untreated Graves' Hyperthyroidism: A Prospective Study
It is claimed that second generation thyrotropin-binding inhibitory immunoglobulin (TBII) assays have a very high sensitivity for the diagnosis of Graves' hyperthyroidism. The authors of this paper investigate.
Journal Article, August 26, 2008
-
CME
Question and Answer Session
Slide/Lecture Presentation, August 26, 2008
-
CME
Obesity, Insulin Resistance, and Atherosclerosis: Can the Cycle Be Broken?
Slide/Lecture Presentation, August 26, 2008
-
CME
Incretin Biology: From Basic Science to Clinical Application
Slide/Lecture Presentation, August 26, 2008
-
CME
Beyond Glycemic Control: Emerging Clinical Strategies for Attenuating Cardiovascular Risk
Slide/Lecture Presentation, August 26, 2008
-
CME
Panel Discussion (Slides With Audio)
Slide/Lecture Presentation, August 26, 2008
-
CME
Panel Discussion (Slides With Transcript)
Slide/Lecture Presentation, August 26, 2008
-
CME
The Role of Neuroendocrine Hormones in Energy Balance and Obesity (Slides With Transcript)
Slide/Lecture Presentation, August 26, 2008
-
CME
The Role of Neuroendocrine Hormones in Energy Balance and Obesity (Slides With Audio)
Slide/Lecture Presentation, August 26, 2008
-
CME
The Clinical Value of Pramlintide as Adjunctive Therapy in Type 2 Diabetes (Slides With Audio)
Slide/Lecture Presentation, August 26, 2008
-
CME
The Clinical Value of Pramlintide as Adjunctive Therapy in Type 2 Diabetes (Slides With Transcript)
Slide/Lecture Presentation, August 26, 2008
-
CME
Clinical Use of Pramlintide in Patients With Type 1 Diabetes (Slides With Audio)
Slide/Lecture Presentation, August 26, 2008
-
CME
Clinical Use of Pramlintide in Patients With Type 1 Diabetes (Slides With Transcript)
Slide/Lecture Presentation, August 26, 2008
